Health Products
Health Products
No. | Title | Status | Download |
---|---|---|---|
231 | Announcement of the Food and Drug Administration Re: Criteria for Food Advertisement B.E.2561 (2018) | Cancel | |
232 | RE: Prescribing the List of Category 5 Narcotics, B.E. 2565 (2022) | ||
233 | RE: Specification of Hemp-Based Formulae of Narcotics of Category V that are Consumable for Treatment of Diseases or Research Study, B.E. 2564 (2021)* | ||
234 | Medical Devices Act, B.E.2551 (2008) and (No. 2), B.E. 2562 (2019) | ||
235 | Cosmetics Act , B.E. 2558 (2015) | ||
236 | Food Act, B.E.2522 (1979) | ||
237 | Re: Temporary Measures for GMP Certificate Consideration of Modern Drug Manufacturing Facilities During the Coronavirus Disease 2019 (COVID-19) Outbreak | ||
238 | Drug Act, B.E.2510 (1967) and amendment 2001 | ||
239 | Herbal Product Act, B.E.2562 (2019) | ||
240 | RE: Prescribing the List of Category 5 Narcotics, B.E. 2563 (2020) |